Sangamo Therapeutics Inc (SGMO)
0.5143
+0.03
(+5.98%)
USD |
NASDAQ |
Apr 19, 16:00
0.5143
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Total Assets (Quarterly): 165.32M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 165.32M |
| September 30, 2023 | 219.70M |
| June 30, 2023 | 325.07M |
| March 31, 2023 | 440.57M |
| December 31, 2022 | 562.51M |
| September 30, 2022 | 593.91M |
| June 30, 2022 | 617.13M |
| March 31, 2022 | 654.31M |
| December 31, 2021 | 721.92M |
| September 30, 2021 | 772.40M |
| June 30, 2021 | 835.36M |
| March 31, 2021 | 877.10M |
| December 31, 2020 | 938.55M |
| September 30, 2020 | 963.71M |
| June 30, 2020 | 894.66M |
| March 31, 2020 | 584.28M |
| December 31, 2019 | 637.52M |
| September 30, 2019 | 640.22M |
| June 30, 2019 | 673.48M |
| March 31, 2019 | 542.73M |
| December 31, 2018 | 590.40M |
| September 30, 2018 | 606.60M |
| June 30, 2018 | 627.73M |
| March 31, 2018 | 281.17M |
| December 31, 2017 | 286.74M |
| Date | Value |
|---|---|
| September 30, 2017 | 269.79M |
| June 30, 2017 | 282.99M |
| March 31, 2017 | 146.81M |
| December 31, 2016 | 157.89M |
| September 30, 2016 | 164.98M |
| June 30, 2016 | 180.91M |
| March 31, 2016 | 197.05M |
| December 31, 2015 | 217.24M |
| September 30, 2015 | 232.52M |
| June 30, 2015 | 229.95M |
| March 31, 2015 | 238.50M |
| December 31, 2014 | 243.21M |
| September 30, 2014 | 247.35M |
| June 30, 2014 | 250.84M |
| March 31, 2014 | 255.50M |
| December 31, 2013 | 140.84M |
| September 30, 2013 | 140.37M |
| June 30, 2013 | 74.20M |
| March 31, 2013 | 75.84M |
| December 31, 2012 | 82.53M |
| September 30, 2012 | 81.81M |
| June 30, 2012 | 86.31M |
| March 31, 2012 | 90.42M |
| December 31, 2011 | 87.34M |
| September 30, 2011 | 88.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
165.32M
Minimum
Dec 2023
963.71M
Maximum
Sep 2020
637.77M
Average
640.22M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 82.43M |
| Shareholders Equity (Quarterly) | 82.89M |
| Current Ratio | 1.976 |